| Title |
Small cell lung cancer.
|
|---|---|
| Published in |
Journal of the National Comprehensive Cancer Network (JNCCN), January 2013
|
| DOI | 10.6004/jnccn.2013.0011 |
| Pubmed ID | |
| Authors |
Gregory P Kalemkerian, Wallace Akerley, Paul Bogner, Hossein Borghaei, Laura Qm Chow, Robert J Downey, Leena Gandhi, Apar Kishor P Ganti, Ramaswamy Govindan, John C Grecula, James Hayman, Rebecca Suk Heist, Leora Horn, Thierry Jahan, Marianna Koczywas, Billy W Loo, Robert E Merritt, Cesar A Moran, Harvey B Niell, Janis O'Malley, Jyoti D Patel, Neal Ready, Charles M Rudin, Charles C Williams, Kristina Gregory, Miranda Hughes |
| Abstract |
Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted. |
Mendeley readers
The data shown below were compiled from readership statistics for 202 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 200 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 36 | 18% |
| Student > Master | 28 | 14% |
| Student > Doctoral Student | 17 | 8% |
| Researcher | 16 | 8% |
| Student > Postgraduate | 14 | 7% |
| Other | 42 | 21% |
| Unknown | 49 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 70 | 35% |
| Agricultural and Biological Sciences | 20 | 10% |
| Biochemistry, Genetics and Molecular Biology | 15 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 6% |
| Engineering | 6 | 3% |
| Other | 21 | 10% |
| Unknown | 57 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 445. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 August 2018.
All research outputs
#63,463
of 25,655,374 outputs
Outputs from Journal of the National Comprehensive Cancer Network (JNCCN)
#22
of 1,746 outputs
Outputs of similar age
#303
of 291,537 outputs
Outputs of similar age from Journal of the National Comprehensive Cancer Network (JNCCN)
#1
of 16 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,746 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,537 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.